<?xml version="1.0" encoding="UTF-8"?>
<p>Data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) in the U.S. indicates that rotavirus gastroenteritis (RVGE) incidence has declined between 57% - 89% since the introduction of vaccines in 2006 [
 <xref rid="pone.0228942.ref003" ref-type="bibr">3</xref>]. Rotavirus hospitalization rates have reduced between 70% - 98%, and all cause diarrhea-associated hospitalization rates declined between 9% - 76% in children under the age of 5 [
 <xref rid="pone.0228942.ref004" ref-type="bibr">4</xref>]. Rotavirus vaccines have also provided indirect benefits to unvaccinated individuals across the age range [
 <xref rid="pone.0228942.ref005" ref-type="bibr">5</xref>].
</p>
